{"id":"W2064680741","doi":"10.1016/j.ejca.2011.11.021","title":"Safety of bevacizumab in metastatic breast cancer patients undergoing surgery","year":2011,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Bevacizumab; Surgery; Metastatic breast cancer; Incidence (geometry); Breast cancer; Adverse effect; Complication; Placebo; Breast surgery; Cancer; Chemotherapy; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006295135,0.0001658924,0.0006749585,0.0001986676,0.0001956027,0.0004965087,0.0001400159,0.0003629783,0.0009198591],"category_scores_gemma":[0.003281208,0.000120094,0.0005419932,0.0002461929,0.0001701404,0.0002965737,0.0001384239,0.0009553186,0.000148873],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005254316,"about_ca_system_score_gemma":0.0004775733,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007468499,"about_ca_topic_score_gemma":0.001349231,"domain_scores_codex":[0.9995054,0.0002328498,0.00003459806,0.00004694443,0.0001214129,0.00005887646],"domain_scores_gemma":[0.9984402,0.0006271782,0.0005795103,0.0000582621,0.0001370923,0.0001576839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1801418,0.001074584,0.5003507,0.0007053844,0.002333564,0.0009796096,0.0003153796,0.001852953,0.0274788,0.000541192,0.002470128,0.281756],"study_design_scores_gemma":[0.007959267,0.102843,0.8531958,0.0002187476,0.002907487,0.004460406,0.0003245314,0.004862986,0.0104083,0.001090306,0.01166588,0.00006319127],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99027,0.007156668,0.0002671593,0.000448985,0.00004834776,0.00002070215,0.0002105725,0.00001241897,0.001565087],"genre_scores_gemma":[0.9983059,0.0008711667,0.00008138413,0.0001633493,0.00006547217,0.000008482257,0.0001974341,0.000003484465,0.0003032965],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009198591,"threshold_uncertainty_score":0.003812253,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04557765805459347,"score_gpt":0.309903347282073,"score_spread":0.2643256892274795,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}